PTPRC and neoplasm: The proportion of both DC subsets relative to all CD45+ cells (including tumor cells) (Figure S5B) was reduced in tumor LNs compared to control conditions; however, the total numbers of cDCs and mDCs remained unchanged (Figure 5D).